Avalon Globocare Granted Notice Of Allowance For U.S. Patent Titled ‘QTY FC FUSION RECEPTOR PROTEINS’
https://patentcenter.uspto.gov/#!/applications/17210878/ifw/docs
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
Avalon GloboCare Corp (NASDAQ: AVCO) is expanding its cellular immuno-oncology program with the
Avalon GloboCare Announces Addition Of CAR-NK Cell Therapies
Leveraging Avalon's existing Flash-CARTM technology platform to develop next-generation mRNA-based CAR-NK cellular therapeutics
Clinical development of CAR-NK cell therapy planned in collaboration
Avalon GloboCare Offers Year-End Business Update Of Selective Scientific, Clinical Programs
Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical programs in the US and Europe
Intended SenlangBio acquisition terminated, eliminating potential 80 million
Avalon GloboCare Reports Chairman Converted Debt Into Common Stock
Avalon GloboCare Corp. (NASDAQ:AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced the Company’s Chairman, Daniel Lu, has converted $3.0